Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
>=1-<5
General Information
Version
2.1
Revision date
2025-06-05
Product name
Eqvalan DUO, oral paste
Product Synonyms
Ivermectin and praziquantel paste, ZIMECTERIN® GOLD, Eqvalan Duo 1.55%+7.75%,1.87%+23.38% oral paste, Ivo- mec Comp 1.55%+7.75% oral paste, Eqvalan Gold 1.55%+7.75% oral paste, Eqvalan P 1.55%+7.75% oral paste, Eqvalan Gold 1.55%+7.75% oral paste, Furexel Combi 1.55%+7.75% oral paste, Molemec Plus 1.55%+7.75% oral paste, Duocare 1.87%+23.38% oral paste with active ingredient: Ivermectin and Praziquantel
1.2.1 Relevant identified uses
Veterinary product
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., For veteri- nary use only, Refer to the product insert for complete instruc- tions on usage
supplier name
Boehringer Ingelheim AH USA
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim AH USA
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H319, H361, H362, H372
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H361 Suspected of damaging fertility or the unborn child. H362 May cause harm to breast-fed children. H372 Causes damage to organs (Central nervous system) through prolonged or repeated exposure if swallowed.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapours. P263 Avoid contact during pregnancy/ while nursing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ P337 + P313 If eye irritation persists: Get medical advice/ atten- tion. P363 Wash contaminated clothing before reuse.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet). This product does not contain titanium dioxide in its respirable form and would not be considered carcinogenic; however, upon crushing, grinding or other processing that could result in the gener- ation of respirable particulates, the Category 2 carcinogenic classification would apply.
2.1 Classification of the substance or mixture
1910.1200) Acute toxicity (Oral) : Category 4 Eye irritation : Category 2A Skin sensitisation : Category 1 Reproductive toxicity : Category 2 Effects on or via lactation Specific target organ toxicity : Category 1 (Central nervous system) - repeated exposure (Oral)
